SIC 8071 – Medical Laboratories
| Valuation | |
|---|---|
| Market Cap ($M) | 430.28 |
| Enterprise Value ($M) | 348.08 |
| Book Value ($M) | 261.33 |
| Book Value / Share | 5.05 |
| Price / Book | 1.65 |
| NCAV ($M) | 108.22 |
| NCAV / Share | 2.09 |
| Price / NCAV | 3.98 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.64 |
| Return on Assets (ROA) | -0.36 |
| Return on Equity (ROE) | -0.45 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 3.77 |
| Current Ratio | 4.02 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 313.71 |
| Assets | 466.83 |
| Liabilities | 205.50 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 280.32 |
| Operating Income | -106.83 |
| Net Income | -190.28 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -18.39 |
| Cash from Investing | 40.45 |
| Cash from Financing | -29.61 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | ArrowMark Colorado Holdings LLC | 0.00 | -100.00 | |
| 13G/A | Bellevue Asset Management (UK) Ltd. | 7.30 | 24.82 | |
| 13G/A | Gagnon Securities Llc | 6.20 | 0.75 | |
| 13G/A | Vanguard Group Inc | 7.62 | -21.83 | |
| 13G | Nikko Asset Management Americas, Inc. | 5.31 | ||
| 13G | Sumitomo Mitsui Trust Holdings, Inc. | 5.31 | ||
| 13G/A | ARK Investment Management LLC | 13.30 | 16.27 | |
| 13G/A | BlackRock Inc. | 10.20 | 1.91 | |
| 13G/A | State Street Corp | 5.17 | -51.35 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 41,918 | 362,520 | 11.56 | |
| 39,789 | 229,764 | 17.32 | |
| 76,779 | 361,566 | 21.24 | |
| 181,829 | 2,009,569 | 9.05 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| BDSX – Biodesix, Inc. | CNTG – Centogene N.V. |
| CSTL – Castle Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io